The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population
Open accessAbstract
OBJECTIVE: To report the mortality of left ventricular systolic dysfunction (LVD), assessed objectively by echocardiography, and its association with natriuretic peptide hormones in a random sample of 1640 men and women aged 25-74 years from a geographical, urban population. METHODS: Left ventricular function was measured by echocardiography in 1640 attendees studied in 1992-3. LVD was defined as a left ventricular ejection fraction (LVEF) </= 30%. Plasma concentrations of N-terminal atrial natriuretic peptide (N-ANP) and brain natriuretic peptide (BNP) were measured by standard radioimmunoassays. Mortality was documented at four years. RESULTS: The four year all cause mortality rate in the whole cohort was 4.9% (80 deaths). It was 21% (nine deaths) in those with an LVEF </= 30% and 4% in those whose LVEF was > 30% (p < 0.001). The median (interquartile range) BNP concentration in those who died was 16.9 pg/ml (8.8-27) and 7.8 pg/ml (3.4-13) in survivors (p < 0.0001). Similarly, N-ANP had a median concentration of 2.35 ng/ml (1.32-3.36) in those with a fatal outcome and 1.27 ng/ml (0.9-2.0) in those alive at four years (p < 0.0001). Subjects with an LVEF </= 40% also had a significant mortality rate of 17% if they also had a BNP concentration >/= 17.9 pg/ml compared with 6.8% if their BNP was below this concentration (p = 0.013). Multivariate analysis revealed the independent predictors of four year all cause mortality to be increasing age (p < 0.001), a BNP concentration >/= 17.9 pg/ml (p = 0.006), the presence of ischaemic heart disease (p = 0.03), and male sex (p = 0.04). CONCLUSIONS: LVD is associated with a considerable mortality rate in this population. BNP also independently predicts outcome. In addition to its role as a diagnostic aid in chronic heart failure and LVD, it provides prognostic information and clarifies the meaning of a given degree of LVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Ho, K. K., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D. (1993) · Circulation · doi:10.1161/01.cir.88.1.107 · Cited by 1,869
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K. R., & Redfield, M. M. (1998) · Circulation · doi:10.1161/01.cir.98.21.2282 · Cited by 1,088
Biochemical detection of left-ventricular systolic dysfunction
McDonagh, T., Robb, S., Murdoch, D., Morton, J., Ford, I., Morrison, C., Tunstall-Pedoe, H., McMurray, J., & Dargie, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03034-1 · Cited by 963
Self-citationPrevalence and mortality rate of congestive heart failure in the United States
Schocken, D. D., Arrieta, M. I., Leaverton, P. E., & Ross, E. A. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90094-4 · Cited by 817
Prineas, R. J., Crow, R. S., & BLACKBURN, H. W. (1982) · Cited by 701
Omland, T., Aakvaag, A., Bonarjee, V. V. S., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J. A., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 700
Richards, A. M., Nicholls, M. G., Yandle, T. G., Frampton, C., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
McDonagh, T. A., Morrison, C. E., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J. J., & Dargie, H. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03033-x · Cited by 630
Self-citationNatriuretic peptide system in human heart failure.
Wei, C. M., Heublein, D. M., Perrella, M. A., Lerman, A., Rodeheffer, R. J., McGregor, C. G., Edwards, W. D., Schaff, H. V., & Burnett, J. C. (1993) · Circulation · doi:10.1161/01.cir.88.3.1004 · Cited by 460
Pacher, R., Stanek, B., Hülsmann, M., Koller-Strametz, J., Berger, R., Schuller, M., Hartter, E., Ogris, E., Frey, B., Heinz, G., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00520-x · Cited by 343
Brain natriuretic peptide as a cardiac hormone in essential hypertension
Kohno, M., Horio, T., Yokokawa, K., Murakawa, K.-I., Yasunari, K., Akioka, K., Tahara, A., Toda, I., Takeuchi, K., Kurihara, N., et al. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90011-y · Cited by 240
Prognostic value of plasma endothelin-1 in patients with chronic heart failure
Pousset, F., Isnard, R., Lechat, P., Kalotka, H., Carayon, A., Maistre, G., Escolano, S., Thomas, D., & Komajda, M. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015228 · Cited by 239
Risk factors for heart failure in the general population: The study of men born in 1913
ERIKSSON, H., SVäRDSUDD, K., LARSSON, B., OHLSON, L. O., TIBBLIN, G., WELIN, L., & WILHELMSEN, L. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059542 · Cited by 238
Atrial Natriuretic Peptide Induces Apoptosis in Neonatal Rat Cardiac Myocytes
Wu, C.-F., Bishopric, N. H., & Pratt, R. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14860 · Cited by 235
Brain natriuretic peptide predicts mortality in the elderly.
Wallén, T., Landahl, S., Hedner, T., Nakao, K., & Saito, Y. (1997) · Heart · doi:10.1136/hrt.77.3.264 · Cited by 172
The Incidence and Prevalence of Congestive Heart Failure in Rochester, Minnesota
Rodeheffer, R. J., Jacobsen, S. J., Gersh, B. J., Kottke, T. E., McCann, H. A., Bailey, K. R., & Ballard, D. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60063-9 · Cited by 157
CLARKSON, P. B. M., Wheeldon, N. M., MacFadyen, R. J., Pringle, S. D., & MacDonald, T. M. (1996) · Circulation · doi:10.1161/01.cir.93.11.2037 · Cited by 105
Cited by
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,324
B-type natriuretic peptide in cardiovascular disease
de Lemos, J. A., McGuire, D. K., & Drazner, M. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13976-1 · Cited by 1,067
Metadata
- Authors
- McDonagh, T. A.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2001-07-01
- Volume
- 86
- Issue
- 1
- Pages
- 21-26
- ISSN
- 0007-0769 (ISSN-L)
- OpenAlex
- W2123671822
- Cited by
- 255
- References
- 21
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.